Should Biotechnology Stock F-Star Therapeutics Inc (FSTX) Be in Your Portfolio Wednesday?

Wednesday, November 17, 2021 01:53 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock F-Star Therapeutics Inc (FSTX) Be in Your Portfolio Wednesday?

F-Star Therapeutics Inc (FSTX) is around the top of the Biotechnology industry according to InvestorsObserver. FSTX received an overall rating of 49, which means that it scores higher than 49 percent of all stocks. F-Star Therapeutics Inc also achieved a score of 75 in the Biotechnology industry, putting it above 75 percent of Biotechnology stocks. Biotechnology is ranked 86 out of the 148 industries.

FSTX has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on FSTX!

See Full FSTX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With F-Star Therapeutics Inc Stock Today?

F-Star Therapeutics Inc (FSTX) stock is trading at $6.14 as of 1:46 PM on Wednesday, Nov 17, a drop of -$0.29, or -4.57% from the previous closing price of $6.43. The stock has traded between $5.84 and $6.44 so far today. Volume today is light. So far 225,150 shares have traded compared to average volume of 321,485 shares. Click Here to get the full Stock Report for F-Star Therapeutics Inc stock.